{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:41:38Z","timestamp":1787625698409,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.atherosclerosis.2021.09.010","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T22:51:29Z","timestamp":1631227889000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["A systematic review and meta-analysis on the effects of statins on pregnancy outcomes"],"prefix":"10.1016","volume":"336","author":[{"given":"Amir","family":"Vahedian-Azimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Bianconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Makvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Momeneh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.118.313245","article-title":"Cholesterol-lowering agents","volume":"124","author":"Hadjiphilippou","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/VHRM.S1653","article-title":"Clinical efficacy and safety of statins in managing cardiovascular risk","volume":"4","author":"Kapur","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib3","series-title":"Effects of Statins on the Biological Features of Mesenchymal Stem Cells and Therapeutic Implications","author":"Gorabi","year":"2020"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8010118","article-title":"Effect of statin therapy on arterial wall inflammation based on 18F-fdg PET\/CT: a systematic review and meta-analysis of interventional studies","volume":"8","author":"Pirro","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/HCO.0000000000000397","article-title":"Statins, haemostatic factors and thrombotic risk","volume":"32","author":"Bianconi","year":"2017","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14656566.2018.1428560","article-title":"Improvement of endothelial function by pitavastatin: a meta-analysis","volume":"19","author":"Katsiki","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib7","doi-asserted-by":"crossref","first-page":"101054","DOI":"10.1016\/j.plipres.2020.101054","article-title":"Antiviral effects of statins","volume":"79","author":"Gorabi","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","article-title":"Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials","volume":"60","author":"Ferretti","year":"2015","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1160\/th15-08-0620","article-title":"The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of Randomised placebo-controlled trials","volume":"115","author":"Sahebkar","year":"2016","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrcardio.2013.80","article-title":"Statins in the primary prevention of cardiovascular disease","volume":"10","author":"Reiner","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib11","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American heart association","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: Part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/tera.1420500604","article-title":"Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits","volume":"50","author":"Dostal","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/tera.1420280316","article-title":"Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase","volume":"28","author":"Minsker","year":"1983","journal-title":"Teratology"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tcb.2006.09.007","article-title":"Sonic hedgehog signaling in forebrain development and its interactions with pathways that modify its effects","volume":"16","author":"Bertrand","year":"2006","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib17","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/humrep\/dei120","article-title":"Simvastatin has deleterious effects on human first trimester placental explants","volume":"20","author":"Kenis","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/erc.11.196","article-title":"Statin use during pregnancy: a systematic review and meta-analysis","volume":"10","author":"Kusters","year":"2012","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/17474108.2013.842684","article-title":"Are statins teratogenic in humans? Addressing the safety of statins in light of potential benefits during pregnancy","volume":"8","author":"Zarek","year":"2013","journal-title":"Expet Rev. Obstet. Gynecol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: a systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1345\/aph.1R202","article-title":"Teratogenic risk of statins in pregnancy","volume":"46","author":"Godfrey","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2021.05.006","article-title":"Fetal toxicity associated with statins: a systematic review and meta-analysis","volume":"327","author":"Vahedian-Azimi","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016052","article-title":"Where are the recommendations on healthy lifestyle and cardiovascular disease prevention for pregnant women?","volume":"9","author":"Banach","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/13543784.2018.1465927","article-title":"The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review","volume":"27","author":"Maierean","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/jog.14295","article-title":"Pravastatin for preeclampsia: from animal to human","volume":"46","author":"Kumasawa","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib26","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1096\/fj.201801104R","article-title":"Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models","volume":"33","author":"Boyle","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities","volume":"84","author":"Finer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib28","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"JPT","year":"2011"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib29","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Bmj"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A","article-title":"A likelihood approach to meta-analysis with random effects","volume":"15","author":"Hardy","year":"1996","journal-title":"Stat. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib33","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib35","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2018.05.038","article-title":"Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: a retrospective review of 39 pregnancies","volume":"277","author":"Botha","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.reprotox.2008.06.009","article-title":"Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes","volume":"26","author":"Taguchi","year":"2008","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib38","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.110.990929","article-title":"Pregnancy outcomes in familial hypercholesterolemia: a registry-based study","volume":"124","author":"Toleikyte","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2125.2007.02905.x","article-title":"Risk of congenital anomalies in pregnant users of statin drugs","volume":"64","author":"Ofori","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/pds.4176","article-title":"Statins during pregnancy: a cohort study using the General Practice Research Database to investigate pregnancy loss","volume":"26","author":"McGrogan","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"Bjog"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib42","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"Bjog"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5603\/GP.a2017.0084","article-title":"An experimental administration of pravastatin in patient with previous, multiple pregnancy losses","volume":"88","author":"Koz\u0142owski","year":"2017","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib45","article-title":"Pravastatin for prevention of HELLP syndrome: a case report","volume":"96","author":"Otten","year":"2017","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib46","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/jog.12053","article-title":"Successful outcome in a rare case of pregnancy with familial hypercholesterolemia and dilated cardiomyopathy","volume":"39","author":"Singh","year":"2013","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib48","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJM200404083501524","article-title":"Central nervous system and limb anomalies in case reports of first-trimester statin exposure","volume":"350","author":"Edison","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0890-6238(96)00130-X","article-title":"Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy","volume":"10","author":"Manson","year":"1996","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib50","series-title":"Preliminary Data on Exposure to Statins during Pregnancy, Clinical Toxicology","author":"McElhatton","year":"2008"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib51","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/bdra.20181","article-title":"Pregnancy outcomes after maternal exposure to simvastatin and lovastatin","volume":"73","author":"Pollack","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vph.2018.06.001","article-title":"Pravastatin and-L-arginine combination improves umbilical artery blood flow and neonatal outcomes in dichorionic twin pregnancies through an nitric oxide-dependent vasorelaxant effect","volume":"110","author":"Jurisic","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib53","article-title":"Effects of statins on preeclampsia: a systematic review","author":"Vahedian-Azimi","year":"2020","journal-title":"Pregnancy Hypertension"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib54","first-page":"41","article-title":"Antiphospholipid Syndrome during pregnancy: the state of the art","volume":"5","author":"Di Prima","year":"2011","journal-title":"J Prenat Med"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib55","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.ajog.2005.05.016","article-title":"Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial","volume":"193","author":"Khoury","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.HYP.0000251522.18094.d4","article-title":"Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?","volume":"49","author":"Germain","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002307","article-title":"Maternal age and severe maternal morbidity: a population-based retrospective cohort study","volume":"14","author":"Lisonkova","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib58","doi-asserted-by":"crossref","first-page":"l869","DOI":"10.1136\/bmj.l869","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000325165","article-title":"Relationship between recurrent miscarriage and insulin resistance","volume":"72","author":"Wang","year":"2011","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib60","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/aogs.13392","article-title":"Increased cardiovascular disease risk in women with a history of recurrent miscarriage","volume":"97","author":"Wagner","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.atherosclerosis.2021.09.010_bib61","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ajog.2012.06.020","article-title":"Can statins reduce the inflammatory response associated with preterm birth in an animal model?","volume":"207","author":"Basraon","year":"2012","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502101337X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502101337X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:46:56Z","timestamp":1758156416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502101337X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":61,"alternative-id":["S002191502101337X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis on the effects of statins on pregnancy outcomes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}